Breast cancer
Theragnostic testing – choosing the right therapy in mTNBCMartina (54 years old)
Martina is 54 years old and used to work as a consultant. She was diagnosed with early stage TNBC at the age of 51. Unfortunately, tumour progression was detected a week ago.
Assessment summary
- Postmenopausal
- No relevant family history
- Genetic testing: no gBRCA1/2 pathogenic variants
- No relevant comorbidities
- ECOG PS: 0
- Medical history
- 3 years ago, diagnosed with early stage TNBC (cT3N2M0, right side)
- Neoadjuvant chemotherapy: anthracycline-taxane + carboplatin
- Mastectomy (right side) and ALND (no pCR: ypT1 ypN1)
- Post-mastectomy radiation therapy
- Post-neoadjuvant capecitabine (6 cycles)
- 1 year ago, staging including CT scan of chest/abdomen and bone scan: 2 liver lesions
- Biopsy (liver lesion)
- Breast cancer, ER 0%, PgR 0%, HER2 IHC 0, G3
- PD-L1 status: CPS 3, IC score 4%
- Therapy with atezolizumab + nab-paclitaxel for 6 months
- Biopsy (liver lesion)
- 3 years ago, diagnosed with early stage TNBC (cT3N2M0, right side)
- Today, CT scan shows progression of the liver lesions and 2 new lung lesions